Gempharm 1gm Injection is a chemotherapy medication containing the active ingredient gemcitabine. It is used to treat bladder, breast, ovarian, pancreatic, and non-small cell lung cancers. Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner. Talk to your doctor if you have heart disease, liver disorders, kidney disorders, recently had radiotherapy, or vaccinated before taking this medicine. 

Gempharm 1gm Injection is not recommended for adolescents and children under the age of 18. Your doctor will assess your blood cell counts and kidney and liver function each time you are given this medicine. Use effective birth control during the treatment and at least six months after the last dose. This injection may impair fertility in male patients. Men taking this medicine are advised not to father a child during the treatment and for 6 months after the treatment.

Tell your physician if you are on a salt-controlled diet, as this medicine contains sodium. Report to your doctor immediately if you experience shortness of breath, wheezing, changes in color or volume of urine, bleeding, or upper abdominal pain while taking Gempharm 1gm Injection.

• Bladder cancer, in combination with cisplatin

• Ovarian cancer, in combination with carboplatin

• Breast cancer, in combination with paclitaxel

• Pancreatic cancer

• Non-small cell lung cancer (NSCLC), alone or in combination with cisplatin.

Gempharm 1gm Injection blocks the ability of cancer cells to process DNA replication, which is essential for the cells to divide and grow. This can prevent or stop the growth of cancer cells.

Inform your healthcare professional about all the medicines you take, including prescription medications, over-the-counter medications, nutritional and vitamin supplements, and herbal products. Certain medications interacting with Gempharm 1gm Injection may reduce effectiveness by causing undesirable side effects.

• Keep Gempharm 1gm Injection out of sight and reach of children.

• This medicine does not require any special storage conditions.

• Do not refrigerate or freeze.

Gempharm 1gm Injection is administered as an intravenous infusion into the vein. If this injection is recommended for you, it will be given by a healthcare professional. Do not self-administer. Your physician will choose the dosage and administration frequency based on the medical condition because it differs for each person.

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.

Serious

• Pulmonary toxicity (shortness of breath, wheezing, cough)

• Hemolytic-uremic syndrome (Changes in the volume or colour of urine, increased bruising, or bleeding)

• Pain or tenderness in the upper abdomen

• Allergic reactions, rashes, fever, swelling or sores in the mouth

Common

• Nausea, vomiting

• Low blood cell count

• Loss of appetite

• Hair loss

• Swelling of ankles, feet, and fingers

• Insomnia

• Constipation, diarrhea

• Headache

• Runny nose, chills

• Muscle pain, back pain

• Sweating

• hair loss

• liver problems

• blood in urine

• abnormal urine test

• Oedema (swelling of ankles, fingers, feet, face)

• Do not take Gempharm 1gm Injection if you are allergic to Gemcitabine or any of its components.

• Your doctor may recommend regular monitoring of blood counts, blood sugar, electrolytes, liver, and kidney function to ensure safe and effective treatment.

• This medicine may impact male fertility.

• Men should avoid fathering a child during treatment and for at least 6 months after the final dose.

• It's important to discuss fertility concerns with your doctor before starting the injection.

• Both men and women should use reliable contraception during treatment and for 6 months after the last dose to prevent pregnancy.